As European politicians consider fundamental reforms to patent protection, one of the key questions
they have to address is how to make the system more efficient. In particular, some critics believe
Europe needs to look to the US model to improve its effectiveness. In a special MIP debate, Koos
Rasser argues that the European patent system as it exists today is substantially inferior to that of the
US, while Simon Mounteney says that, though not perfect, Europe offers many benefits to applicants
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats